BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9918426)

  • 21. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes.
    Ogawa S; Takeuchi K; Ito S
    Diabetes Obes Metab; 2004 Sep; 6(5):384-90. PubMed ID: 15287932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acarbose, an alpha-glucosidase inhibitor, improves insulin resistance in fructose-fed rats.
    Nakamura K; Yamagishi S; Matsui T; Inoue H
    Drugs Exp Clin Res; 2005; 31(4):155-9. PubMed ID: 16223205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acarbose (glucobai) effects on lipid metabolism in patients with non-insulin dependent diabetes mellitus].
    Rosliakova LV; Roĭtman AP; Ametov AS; Dolgov VV
    Ter Arkh; 2000; 72(8):54-6. PubMed ID: 11019430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1359-65. PubMed ID: 8667198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of somatostatin in dumping syndrome].
    Tulassay Z; Tulassay T; Szathmári M; Gohér A; Tamás G
    Orv Hetil; 1990 Nov; 131(44):2417-20. PubMed ID: 1978748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The alpha (α)-glucosidase inhibitor, acarbose, attenuates the blood pressure and splanchnic blood flow responses to intraduodenal sucrose in older adults.
    Gentilcore D; Vanis L; Wishart JM; Rayner CK; Horowitz M; Jones KL
    J Gerontol A Biol Sci Med Sci; 2011 Aug; 66(8):917-24. PubMed ID: 21628676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage.
    Frati Munari AC; Benítez Pinto W; Raúl Ariza Andraca C; Casarrubias M
    Arch Med Res; 1998; 29(2):137-41. PubMed ID: 9650328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a medical food containing an herbal alpha-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults.
    Heacock PM; Hertzler SR; Williams JA; Wolf BW
    J Am Diet Assoc; 2005 Jan; 105(1):65-71. PubMed ID: 15635348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seven-day subcutaneous continuous glucose monitoring demonstrates that treatment with acarbose attenuates late dumping syndrome in a woman with gastrectomy for gastric cancer.
    Buscemi S; Mattina A; Genova G; Genova P; Nardi E; Costanzo M
    Diabetes Res Clin Pract; 2013 Jan; 99(1):e1-2. PubMed ID: 23146372
    [No Abstract]   [Full Text] [Related]  

  • 30. A review of the safety and efficacy of acarbose in diabetes mellitus.
    Yee HS; Fong NT
    Pharmacotherapy; 1996; 16(5):792-805. PubMed ID: 8888075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Short term assessment of anthropometric indices and metabolic parameters in obese subjects treated with acarbose].
    Coli P; Pea E; Lacorte M; Passaglia C; Carrai M
    Minerva Med; 1996 Apr; 87(4):161-70. PubMed ID: 8700340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K; Hillebrand I
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract]   [Full Text] [Related]  

  • 33. Beneficial effects of acarbose on familiar hypertriglyceridemias.
    Malaguarnera M; Giugno I; Panebianco MP; Pistone G
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):441-5. PubMed ID: 9726698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
    Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
    Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome.
    Lyons TJ; McLoughlin JC; Shaw C; Buchanan KD
    Digestion; 1985; 31(2-3):89-96. PubMed ID: 3888753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
    Schwartzkopff W; Calder D
    Med Welt; 1984 Feb; 35(6):169-74. PubMed ID: 6369065
    [No Abstract]   [Full Text] [Related]  

  • 37. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
    Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
    Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemia pathogenesis in children with dumping syndrome.
    Rivkees SA; Crawford JD
    Pediatrics; 1987 Dec; 80(6):937-42. PubMed ID: 3317264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of acarbose in the treatment of elderly patients with postprandial hypotension.
    Jian ZJ; Zhou BY
    Chin Med J (Engl); 2008 Oct; 121(20):2054-9. PubMed ID: 19080275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acarbose treatment of infant dumping syndrome: extensive study of glucose dynamics and long-term follow-up.
    Zung A; Zadik Z
    J Pediatr Endocrinol Metab; 2003; 16(6):907-15. PubMed ID: 12948306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.